Showing results (491-500 of 568) with videos related to
Sort By:
Pageof 57
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigenA Hameg, I Apostolou, M Leite-De-Moraes, et al.Revue Neurologique|January 1, 1989
[Myasthenia and pregnancy: a clinical and immunologic study of 42 cases (21 neonatal myasthenia cases)]B Eymard, E Morel, O Dulac, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1986
Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunityL Chatenoud, B Dugas, G Beaurain, et al.Journal of the Neurological Sciences|August 1, 1988
Effect of myasthenic patient sera on the number and distribution of acetylcholine receptors in muscle and nerve-muscle cultures from rat. Correlations with clinical stateB Eymard, S de la Porte, C Pannier, et al.European Journal of Immunology|September 1, 1994
Induction of soluble tumor necrosis factor receptor (sTNF-R75) release by HIV adsorption on cultured human monocytesA C Rimaniol, F Boussin, A Herbelin, et al.Transplantation|March 1, 1991
Differential in situ expression of cytokines in renal allograft rejectionC Vandenbroecke, S Caillat-Zucman, C Legendre, et al.Journal of Autoimmunity|January 8, 1999
Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic childrenA M Yamamoto, I Deschamps, H J Garchon, et al.Arthritis and Rheumatism|March 23, 2000
Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseasesA M Yamamoto, Z Amoura, C Johannet, et al.Annals of Neurology|March 1, 1995
A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19pK Vahedi, A Joutel, P Van Bogaert, et al.Nephrologie|January 1, 1987
[Preventive treatment of rejection by the prolonged administration of OKT3: decrease of the immune response of the host]A Debure, N Chkoff, L Chatenoud, et al.Pageof 57